Infectious Disease Clinics of North America volume 19, issue 2, P387-406 2005 DOI: 10.1016/j.idc.2005.03.001 View full text
|
|
Share
Jack D. Sobel

Abstract: The use of biochemical profiles and new molecular microbiologic methodologies is transforming our understanding of BV. Most important is the recognition of different subgroups of women who have BV who are at variable risk of certain obstetric and gynecologic complications. New diagnostic tests may soon be available that will allow women to test self-obtained specimens. Treatment of BV has lagged, although innovative methods appear to be helpful in managing recurrent diseases.